Advertisement
Home 2015

Archives

The U.S. Food and Drug Administration has issued final recommendations for the cleaning and sterilization of medical devices used in invasive procedures. The updated rules

FDA Updates Recs for Cleaning of Reusable Med Devices

0
Updated rules in response to contaminated duodenoscopes
The nationwide Physician Misery Index is 3.7 out of 5

Frustrated by Regulations, Doctors Increasingly Miserable

0
Geneia and physicians introduce initiative to share ideas to restore the joy to medicine
Physicians should begin planning their exit strategy three to five years in advance

Physicians Should Plan Exit Strategy in Advance

0
Planning 3 to 5 years in advance recommended; practice can be transitioned rather than closed
The expected shortfall of physicians is projected to reach about 46

AAMC: Significant Shortfall of Physicians Projected for 2025

0
Demand for physicians increasing faster than supply; shortfall expected to reach 46,100 to 90,400 by 2025
Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma.

FDA Approves Unituxin for High-Risk Neuroblastoma

0
First approval for a therapy aimed specifically to treat the rare pediatric cancer
Cresemba (isavuconazonium sulfate) has been approved by the U.S. Food and Drug Administration to treat invasive aspergillosis and invasive mucormycosis

FDA Approves Cresemba for Serious Fungal Infections

0
New drug targets cell walls of the fungi; available in oral and intravenous formulations
A new cardiopulmonary resuscitation system designed to increase the chance of survival in people experiencing cardiac arrest has been approved by the U.S. Food and Drug Administration.

FDA Approves New CPR Devices

0
Used together, they up the amount of oxygenated blood circulating through the body during CPR
The U.S. Food and Drug Administration has approved the first device to treat dialysis-related amyloidosis (DRA)

FDA: Device Authorized for Use in Dialysis-Related Amyloidosis

0
Lixelle Beta 2-microglobulin Apheresis Column authorized for use in DRA
The U.S. Food and Drug Administration has approved Zarxio (filgrastim-sndz)

FDA Approves First Biosimilar Drug in U.S.

0
Zarxio is highly similar to long-sanctioned cancer drug
A mobile phone application has been released to identify current drug shortages

FDA Launches First App to Identify Drug Shortages

0
App IDs shortages, resolved shortages, product discontinuation; can be used to report shortages